future of protein production with plates with healthy food and protein

Carlsberg spinout Traitomic raises US$22 million for crop and microbial trait development

November 18, 2026

Traitomic has raised US$22 million (€20 million) in a Series A round to expand internationally and help more customers develop traits for agriculture, food production and industrial biotechnology. The Copenhagen-based company uses a screening platform developed at Carlsberg Research Laboratory to identify useful genetic variants in plants and microorganisms without gene editing.

• Sofinnova Partners led Traitomic’s first external funding round.
• Traitomic has delivered 116 traits to 47 customers across 32 organisms.
• The company plans to hire in the US and Australia.

“Over the past years, we have demonstrated that customers across the food value chain are looking for faster routes from biological insight to commercial impact,” said Gustav Hambraeus, CEO and co-founder of Traitomic. “With the support of our new investors, we can now expand internationally, deepen our collaboration with customers and bring our integrated approach to trait development to many more innovation challenges.”

The Export and Investment Fund of Denmark (EIFO), Footprint Firm, Nordic Foodtech VC, PSV Hafnium and SVG Ventures joined Sofinnova Partners in the round. It was Traitomic’s first external investment since its spinout from Carlsberg.

Traitomic’s FIND-IT platform, originally developed to improve brewing barley, can screen both plants and microorganisms without gene editing

Traitomic’s FIND-IT platform identifies specific genetic variants in conventionally bred populations. The technology was originally developed to improve barley for brewing, and Traitomic now applies it to both plants and microorganisms. The company said it had delivered 116 traits to 47 customers across 32 organisms, with projects spanning seed and plant breeding, food and nutrition, and industrial biotechnology.

In agriculture, Traitomic has worked on traits linked to crop yield and resilience. Food projects have targeted flavor, nutritional characteristics and shelf life, while its industrial biotechnology work has included improving enzymes and microbial strains.

The funding will also allow Traitomic to expand the work it does alongside customers. A project can begin with a commercial need, such as a food manufacturer looking to extend a product’s shelf life, or with a biological characteristic a customer already wants to develop. Traitomic can help define the trait, identify and assess suitable variants, and support the handover to the customer.

Traitomic screens conventionally bred populations for genetic variants linked to traits such as crop yield and resilience

“Traitomic has demonstrated something that is rare in biological innovation: the ability to develop commercially relevant traits across a broad range of organisms and applications,” said Michael Krel, Partner at Sofinnova Partners. He cited the company’s customer base and record of delivering traits as reasons for backing its international expansion.

Anders Røed, Executive Vice President, Group Strategy & Commercial at Carlsberg, said the brewer would continue to support the company. “FIND-IT was developed at Carlsberg Research Laboratory to improve barley, and it is now enabling advances in agriculture, food production and industrial biotechnology,” he said.

(Main picture, from left, shows Traitomic co-founders Toni Wendt, Technology Lead, Jan Gottlieb, Commercial Lead, and Gustav Hambraeus, CEO)‍

‍If you liked this, check these out...

• Lantmännen introduces NordPea with Ingredion as Swedish protein plant nears completion‍
• GreenVenus and Plant Research partner to develop climate-resilient field pea varieties‍
• SentiaNova launches patented pea protein technology to remove off-flavors and cut formulation costs

Join Us At One Of Our Upcoming Events

If you have any questions or would like to get in touch with us, please email info@futureofproteinproduction.com

About the Speaker

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.